Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Clinical trial NCT03717298 · COMPLETED

Trial details

NCT number: NCT03717298
Sponsor: Catalysis SL
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Pancreas Pancreatic Cancer Advanced Cancer Digestive System Neoplasms Pancreatic Neoplasms Endocrine Gland Neoplasms Digestive System Diseases Endocrine System Diseases Pancreatic Diseases

Start date: 2018-10-30
Primary completion: 2022-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.